Form D · Other Health Care

Q'Apel Medical, Inc.

Fremont, CA · CIK 0001846813

Offering snapshot reported May 9, 2024 · SEC filing

Reported sold
$17.1M
Offering amount: $42.1M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 26, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 9, 2024Initial$17,130,411No comparison6SEC filing
May 10, 2022Amendment$29,897,481$859,784vs Apr 4, 20227SEC filing
Apr 4, 2022Initial$29,037,697No comparison3SEC filing
Feb 18, 2021Initial$21,899,996No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-512834
$10,000,000.69 new cash; $7,130,411.24 conversion of debt

Source: Form D, filed May 9, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Scot Huennekens Director
Scott Huennekens Director
Lennox Ketner Director
Christopher Martin Director
Carter Mc Nabb Director
R. King Nelson Director, Executive
J. Avi Roop Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
4245 Technology Drive
Fremont, CA, 94538